Clinical Trials Directory

Trials / Completed

CompletedNCT02383043

Impact of Sustained Release d-Amphetamine on Choice Between Cocaine and a Non-Drug Reinforcer

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Joshua A. Lile, Ph.D. · Academic / Other
Sex
All
Age
21 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Cocaine-use disorders continue to be a significant public health concern, yet no effective medications have been identified. The goal of this study is to establish a research platform for the development of medications for treatment of cocaine abuse and dependence. This study will incorporate choice self-administration procedures between drug and a non-drug alternative reinforcer presented during maintenance on d-amphetamine, which has been previously shown to reduce cocaine use.

Conditions

Interventions

TypeNameDescription
DRUGCocaine
DRUGSustained Release d-Amphetamine

Timeline

Start date
2015-02-01
Primary completion
2018-04-05
Completion
2018-04-05
First posted
2015-03-09
Last updated
2019-04-11
Results posted
2019-04-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02383043. Inclusion in this directory is not an endorsement.

Impact of Sustained Release d-Amphetamine on Choice Between Cocaine and a Non-Drug Reinforcer (NCT02383043) · Clinical Trials Directory